European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer

. 2021 Sep ; 154 () : 316-328. [epub] 20210729

Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid34333209
Odkazy

PubMed 34333209
DOI 10.1016/j.ejca.2021.06.004
PII: S0959-8049(21)00368-3
Knihovny.cz E-zdroje

BACKGROUND: Long-term follow-up (LTFU) care for childhood, adolescent, and young adult (CAYA) cancer survivors is essential to preserve health and quality of life (QoL). Evidence-based guidelines are needed to inform optimal surveillance strategies, but many topics are yet to be addressed by the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG). Therefore, the PanCareFollowUp Recommendations Working Group collaborated with stakeholders to develop European harmonised recommendations in anticipation of evidence-based IGHG guidelines. METHODS: The PanCareFollowUp Recommendations Working Group, consisting of 23 late effects specialists, researchers, and survivor representatives from nine countries, collaborated in the first Europe-wide effort to provide unified recommendations in anticipation of evidence-based guidelines. A pragmatic methodology was used to define recommendations for topics where no evidence-based IGHG recommendations exist. The objective was to describe the surveillance requirements for high-quality care while balancing the different infrastructures and resources across European health care systems. The process included two face-to-face meetings and an external consultation round involving 18 experts from 14 countries. RESULTS: Twenty-five harmonised recommendations for LTFU care were developed collaboratively and address topics requiring awareness only (n = 6), awareness, history and/or physical examination (n = 9), or additional surveillance tests (n = 10). CONCLUSIONS: The PanCareFollowUp Recommendations, representing a unique agreement across European stakeholders, emphasise awareness among survivors and health care providers in addition to tailored clinical evaluation and/or surveillance tests. They include existing IGHG guidelines and additional recommendations developed by a pragmatic methodology and will be used in the Horizon 2020-funded PanCareFollowUp project to improve health and QoL of CAYA cancer survivors.

Childhood Cancer International Europe Servitengasse 5 16 Vienna 1090 Austria

Department of Hematology Radboud Institute for Health Sciences Radboud University Medical Centre Geert Grooteplein Zuid 10 Nijmegen 6525 GA the Netherlands

Department of Oncology Paediatric Oncology KU Leuven Belgium

Department of Oncology Paediatric Oncology KU Leuven Belgium; Department of Paediatric Haematology and Oncology University Hospitals Leuven Herestraat 49 Leuven 3000 Belgium

Department of Paediatric and Adolescent Medicine Kepler University Clinic 26 30 Krankenhausstraße Linz 4020 Austria; Great North Children's Hospital Royal Victoria Infirmary Queen Victoria Road Newcastle upon Tyne NE1 4 LP UK; Translational and Clinical Research Institute Wolfson Childhood Cancer Research Centre Herschel Building Brewery Lane Newcastle upon Tyne NE1 7RU UK

Epidemiology and Biostatistics Unit and DOPO Clinic IRCCS Istituto Giannina Gaslini Via G Gaslini 5 Genoa 16147 Italy

European Society for Paediatric Oncology c o BLSI Clos Chapelle aux Champs 30 Bte 1 30 30 Brussels BE 1200 Belgium

European Society for Paediatric Oncology c o BLSI Clos Chapelle aux Champs 30 Bte 1 30 30 Brussels BE 1200 Belgium; Childhood Cancer Research Group Danish Cancer Society Research Centre Strandboulevarden 49 Copenhagen 2100 Denmark; Department of Clinical Medicine Faculty of Health Aarhus University and Aarhus University Hospital Palle Juul Jensens Boulevard 82 Aarhus 8200 Denmark

Great Ormond Street Hospital for Children NHS Foundation Trust Great Ormond Street London WC1N 3JH UK

International Clinical Research Center at St Anne's University Hospital Masaryk University Pekařská 53 Brno 656 91 Czech Republic

Oncology Department of Clinical Sciences Lund Lund University Skane University Hospital Lasarettsgatan 40 Lund 221 85 Sweden

Paediatrics Department of Clinical Sciences Lund Lund University Skane University Hospital Lasarettsgatan 40 Lund 221 85 Sweden

PanCare Jacobus Bellamylaan 16 Bussum 1401 AZ the Netherlands; Childhood Cancer International Europe Servitengasse 5 16 Vienna 1090 Austria

PanCare Jacobus Bellamylaan 16 Bussum 1401 AZ the Netherlands; St Anna Children's Hospital Kinderspitalgasse 6 Vienna 1090 Austria; Department of Paediatric and Adolescent Medicine Kepler University Clinic 26 30 Krankenhausstraße Linz 4020 Austria

Population Health Sciences Institute Newcastle University Sir James Spence Institute Royal Victoria Infirmary Queen Victoria Road Newcastle upon Tyne NE1 4LP UK; Newcastle University Centre for Cancer Wolfson Childhood Cancer Research Centre Herschel Building Brewery Lane Newcastle upon Tyne NE1 7RU UK

Princess Máxima Centre for Paediatric Oncology Heidelberglaan 25 Utrecht 3584 CS the Netherlands

Princess Máxima Centre for Paediatric Oncology Heidelberglaan 25 Utrecht 3584 CS the Netherlands; Department of Paediatrics Emma Children's Hospital Amsterdam UMC Meibergdreef 9 Amsterdam 1105 AZ the Netherlands; Faculty of Medicine Utrecht University and Utrecht Medical Centre Universiteitsweg 98 Utrecht 3584 CG the Netherlands

Princess Máxima Centre for Paediatric Oncology Heidelberglaan 25 Utrecht 3584 CS the Netherlands; PanCare Jacobus Bellamylaan 16 Bussum 1401 AZ the Netherlands

Citace poskytuje Crossref.org

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...